Search Results - "WEISENBACH, S"

Evolving Beyond Average: A Commentary on Murai et al. (2024) by Weisenbach, S. L., Gregg, A. P.

Get full text

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo by KLEIN, J. C, EGGERS, C, KALBE, E, WEISENBACH, S, HOHMANN, C, VOLLMAR, S, BAUDREXEL, S, DIEDERICH, N. J, HEISS, W. D, HILKER, R

“…Although Parkinson disease with dementia (PDD) and dementia with Lewy bodies (DLB) show a wide clinical and neuropathologic overlap, they are differentiated…”
Get full text

Dementia in Parkinson disease : Functional imaging of cholinergic and dopaminergic pathways by HILKER, R, THOMAS, A. V, KLEIN, J. C, WEISENBACH, S, KALBE, E, BURGHAUS, L, JACOBS, A. H, HERHOLZ, K, HEISS, W. D

“…To assess neurochemical deficits in patients with Parkinson disease (PD) associated dementia (PDD) in vivo. The authors performed combined PET with…”
Get full text

Considering sex differences clarifies the effects of depression on facial emotion processing during fMRI by Jenkins, L.M., Kendall, A.D., Kassel, M.T., Patrón, V.G., Gowins, J.R., Dion, C., Shankman, S.A., Weisenbach, S.L., Maki, P., Langenecker, S.A.

“…Sex differences in emotion processing may play a role in women's increased risk for Major Depressive Disorder (MDD). However, studies of sex differences in…”
Get full text

Deficits of the cholinergic system in early AD by Herholz, Karl, Weisenbach, S., Kalbe, E.

“…Impairment of cholinergic neurotransmission is a well-established fact in Alzheimer's disease (AD) but there is controversy about its relevance at the early…”
Get full text

Shifted inferior frontal laterality in women with major depressive disorder is related to emotion-processing deficits by Briceño, E M, Weisenbach, S L, Rapport, L J, Hazlett, K E, Bieliauskas, L A, Haase, B D, Ransom, M T, Brinkman, M L, Peciña, M, Schteingart, D E, Starkman, M N, Giordani, B, Welsh, R C, Noll, D C, Zubieta, J-K, Langenecker, S A

“…Facial emotion perception (FEP) is a critical human skill for successful social interaction, and a substantial body of literature suggests that explicit FEP is…”
Get more information

A pilot investigation of differential neuroendocrine associations with fronto-limbic activation during semantically-cued list learning in mood disorders by Peters, A.T., Smith, R.A., Kassel, M.T., Hagan, M., Maki, P., Van Meter, A., Briceño, E.M., Ryan, K.A., Weldon, A.L., Weisenbach, S.L., Starkman, M.N., Langenecker, S.A.

“…•Cortisol predicted activation in several associative memory regions.•Cortisol predicted hypoactivation of several of these regions in mood disorders.•Cortisol…”
Get full text

In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease by Herholz, K, Weisenbach, S, Zündorf, G, Lenz, O, Schröder, H, Bauer, B, Kalbe, E, Heiss, W.-D

“…It is currently unclear whether impairment of the cholinergic system is present in Alzheimer disease (AD) already at an early stage and to what extent it…”
Get full text

Anosognosia in very mild Alzheimer's disease but not in mild cognitive impairment by Kalbe, E, Salmon, E, Perani, D, Holthoff, V, Sorbi, S, Elsner, A, Weisenbach, S, Brand, M, Lenz, O, Kessler, J, Luedecke, S, Ortelli, P, Herholz, K

“…To study awareness of cognitive dysfunction in patients with very mild Alzheimer's disease (AD) and subjects with mild cognitive impairment (MCI). A complaint…”
Get more information

Evolving Beyond Average: A Commentary on Murai et al. (2024) by Weisenbach, S L, Gregg, A P

“…Practice effects and IIV have the added benefit of being relatively easy to incorporate in study design with NHP, as modification of planned analyses would not…”
Get full text

The Double Burden of Depression and Age on Memory Performance by O'Mara, A, Briceno, E, Avery, E, Zubieta, J, Langenecker, S, Weisenbach, S

“…Objective: Major Depressive Disorder (MDD) and normal aging are both known to impact memory performance. This study was designed to investigate the interactive…”
Get full text

AGING AND DEMENTIA: HEALTHY AGING AND COGNITIONB-14The Double Burden of Depression and Age on Memory Performance by O'Mara, A, Briceno, E, Avery, E, Zubieta, J, Langenecker, S, Weisenbach, S

Get full text

Subthalamic Nucleus Stimulation Restores Glucose Metabolism in Associative and Limbic Cortices and in Cerebellum: Evidence from a FDG-PET Study in Advanced Parkinson's Disease by Hilker, Ruediger, Voges, Juergen, Weisenbach, Simon, Kalbe, Elke, Burghaus, Lothar, Ghaemi, Mehran, Lehrke, Ralph, Koulousakis, Athanasios, Herholz, Karl, Sturm, Volker, Heiss, Wolf-Dieter

“…Deep brain stimulation of the subthalamic nucleus (STN-DBS) is a highly effective surgical treatment in patients with advanced Parkinson's disease (PD)…”
Get full text

Deficits of the cholinergic system in early AD: Neuroimaging of Early Alzheimer's Disease by HERHOLZ, Karl, WEISENBACH, S, KALBE, E

Get full text

Measuring Cortical Acetylcholine Esterase Activity by PET in Dementia: Clinical Correlates by Herholz, K., Weisenbach, S., Hilker, R., Heiss, W.

“…The acetylcholine analogue C-11- N-methyl-4-piperidinyl-acetate (MP4A) is a tracer for positron emission tomography (PET) to investigate the integrity of the…”
Get full text

Cerebral acetylcholine esterase activity in mild cognitive impairment by Herholz, Karl, Weisenbach, Simon, Kalbe, Elke, Diederich, Nico J, Heiss, Wolf-Dieter

“…Mild cognitive impairment may be an early clinical manifestation of Alzheimerʼs disease, but there are also patients who remain stable or remit. In-vivo…”
Get full text

Auditory Memory Decrements, Without Dissimulation, among Patients with Major Depressive Disorder by Considine, Ciaran M., Weisenbach, Sara L., Walker, Sara J., McFadden, E. Michelle, Franti, Lindsay M., Bieliauskas, Linas A., Maixner, Daniel F., Giordani, Bruno, Berent, Stanley, Langenecker, Scott A.

“…Questions have been raised about whether poor performance on memory tasks by individuals with major depressive disorder (MDD) might be the result of poor or…”
Get full text

Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease by Anchisi, Davide, Borroni, Barbara, Franceschi, Massimo, Kerrouche, Nasser, Kalbe, Elke, Beuthien-Beumann, Bettina, Cappa, Stephano, Lenz, Olaf, Ludecke, Stephan, Marcone, Alessandra, Mielke, Rüdiger, Ortelli, Paola, Padovani, Alessandro, Pelati, Oriana, Pupi, Alberto, Scarpini, Elio, Weisenbach, Simon, Herholz, Karl, Salmon, Erik, Holthoff, Vjera, Sorbi, Sandro, Fazio, Ferruccio, Perani, Daniela

“…Subjects with amnesic mild cognitive impairment (aMCI) may include patients at high risk for progression to Alzheimer disease (AD) and a population with…”
Get more information

Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity by Hilker, Ruediger, Schweitzer, Katherine, Coburger, Silke, Ghaemi, Mehran, Weisenbach, Simon, Jacobs, Andreas H, Rudolf, Jobst, Herholz, Karl, Heiss, Wolf-Dieter

“…The investigation of disease progression provides important information on the dynamics of cell death in Parkinson disease (PD). To determine the progression…”
Get more information

[ 18F]fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson's disease by Hilker, Ruediger, Razai, Noushin, Ghaemi, Mehran, Weisenbach, Simon, Rudolf, Jobst, Szelies, Brigitte, Heiss, Wolf-Dieter

“…Sleep disturbances are common in patients with Parkinson's disease (PD). Previous studies have shown alterations of polysomnographic sleep parameters in PD,…”
Get full text